Demyelination and Remyelination in Multiple Sclerosis (MS) Detected by Brain Amyloid PET-CT
Multiple Sclerosis
About this trial
This is an interventional basic science trial for Multiple Sclerosis focused on measuring MRI, 18F-Florbetaben PET/CT
Eligibility Criteria
Inclusion Criteria: progressive stage of multiple sclerosis (both secondary and primary, SMP) patients in relapsing-remitting multiple sclerosis (RRMS) Exclusion Criteria: a disability greater than 7 patients with a cognitive impairment interfering with full study participation (Minimental score less than 24) patients with internal medical problems that in the opinion of the investigator may interfere with full participation and collaboration inability to undergo MRI or PET examinations ongoing pregnancy and lactation
Sites / Locations
- ICS Maugeri SpA SB IRCCSRecruiting
Arms of the Study
Arm 1
Experimental
18F-Florbetaben PET/CT scan
All the partecipants will undergo PET/CT scan evaluation after 18F-florbetaben administration